Subthalamic, not striatal, activity correlates with basal ganglia downstream activity in normal and parkinsonian monkeys

  1. Marc Deffains  Is a corresponding author
  2. Liliya Iskhakova
  3. Shiran Katabi
  4. Suzanne N Haber
  5. Zvi Israel
  6. Hagai Bergman
  1. The Hebrew University-Hadassah Medical School, Israel
  2. University of Rochester School of Medicine, United States
  3. Hadassah University Hospital, Israel

Abstract

The striatum and the subthalamic nucleus (STN) constitute the input stage of the basal ganglia (BG) network and together innervate BG downstream structures using GABA and glutamate, respectively. Comparison of the neuronal activity in BG input and downstream structures reveals that subthalamic, not striatal, activity fluctuations correlate with modulations in the increase/decrease discharge balance of BG downstream neurons during temporal discounting classical condition task. After induction of parkinsonism with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), abnormal low beta (8-15 Hz) spiking and local field potential (LFP) oscillations resonate across the BG network. Nevertheless, LFP beta oscillations entrain spiking activity of STN, striatal cholinergic interneurons and BG downstream structures, but do not entrain spiking activity of striatal projection neurons. Our results highlight the pivotal role of STN divergent projections in BG physiology and pathophysiology and may explain why STN is such an effective site for invasive treatment of advanced Parkinson's disease and other BG-related disorders.

Article and author information

Author details

  1. Marc Deffains

    Department of Medical Neurobiology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
    For correspondence
    marcd@ekmd.huji.ac.il
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0734-6541
  2. Liliya Iskhakova

    Department of Medical Neurobiology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  3. Shiran Katabi

    Department of Medical Neurobiology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  4. Suzanne N Haber

    Department of Pharmacology and Physiology, University of Rochester School of Medicine, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Zvi Israel

    Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
  6. Hagai Bergman

    Department of Medical Neurobiology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2402-6673

Funding

The Edmond and Lily Safra Center

  • Marc Deffains
  • Liliya Iskhakova

The Rosetrees and Vorst Foundations (ROSETREES 251112 and ROSETREES TRUST 271010)

  • Hagai Bergman

The Simone and Bernard Guttman Chair in Brain Research

  • Hagai Bergman

Ministry of Aliyah and Immigrant Absorption

  • Liliya Iskhakova

The Teva National Network of Excellence in Neuroscience

  • Liliya Iskhakova

The Israel-US Binational Science Foundation

  • Suzanne N Haber
  • Zvi Israel
  • Hagai Bergman

The Adelis Foundation

  • Suzanne N Haber
  • Zvi Israel
  • Hagai Bergman

European Research Council (GA 322495 CLUE-BGD 098777)

  • Hagai Bergman

Israel Science Foundation

  • Hagai Bergman

The German Israel Science Foundation (I-1222-377.13/2010 002223)

  • Hagai Bergman

The Canadian Friends of the Hebrew University

  • Hagai Bergman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Rui M Costa, Fundação Champalimaud, Portugal

Ethics

Animal experimentation: All experimental protocols were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and with the Hebrew University guidelines for the use and care of laboratory animals in research, supervised by the institutional animal care and use committee of the faculty of medicine, the Hebrew University, Jerusalem, Israel (Ethical Application Reference Number: MD-15-14412-5 ). The Hebrew University is an Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) internationally accredited institute.

Version history

  1. Received: March 29, 2016
  2. Accepted: August 22, 2016
  3. Accepted Manuscript published: August 23, 2016 (version 1)
  4. Version of Record published: September 20, 2016 (version 2)

Copyright

© 2016, Deffains et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,439
    views
  • 729
    downloads
  • 87
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marc Deffains
  2. Liliya Iskhakova
  3. Shiran Katabi
  4. Suzanne N Haber
  5. Zvi Israel
  6. Hagai Bergman
(2016)
Subthalamic, not striatal, activity correlates with basal ganglia downstream activity in normal and parkinsonian monkeys
eLife 5:e16443.
https://doi.org/10.7554/eLife.16443

Share this article

https://doi.org/10.7554/eLife.16443

Further reading

    1. Neuroscience
    Amanda Chu, Nicholas T Gordon ... Michael A McDannald
    Research Article

    Pavlovian fear conditioning has been extensively used to study the behavioral and neural basis of defensive systems. In a typical procedure, a cue is paired with foot shock, and subsequent cue presentation elicits freezing, a behavior theoretically linked to predator detection. Studies have since shown a fear conditioned cue can elicit locomotion, a behavior that - in addition to jumping, and rearing - is theoretically linked to imminent or occurring predation. A criticism of studies observing fear conditioned cue-elicited locomotion is that responding is non-associative. We gave rats Pavlovian fear discrimination over a baseline of reward seeking. TTL-triggered cameras captured 5 behavior frames/s around cue presentation. Experiment 1 examined the emergence of danger-specific behaviors over fear acquisition. Experiment 2 examined the expression of danger-specific behaviors in fear extinction. In total, we scored 112,000 frames for nine discrete behavior categories. Temporal ethograms show that during acquisition, a fear conditioned cue suppresses reward seeking and elicits freezing, but also elicits locomotion, jumping, and rearing - all of which are maximal when foot shock is imminent. During extinction, a fear conditioned cue most prominently suppresses reward seeking, and elicits locomotion that is timed to shock delivery. The independent expression of these behaviors in both experiments reveal a fear conditioned cue to orchestrate a temporally organized suite of behaviors.

    1. Neuroscience
    Salima Messaoudi, Ada Allam ... Isabelle Caille
    Research Article

    The fragile X syndrome (FXS) represents the most prevalent form of inherited intellectual disability and is the first monogenic cause of autism spectrum disorder. FXS results from the absence of the RNA-binding protein FMRP (fragile X messenger ribonucleoprotein). Neuronal migration is an essential step of brain development allowing displacement of neurons from their germinal niches to their final integration site. The precise role of FMRP in neuronal migration remains largely unexplored. Using live imaging of postnatal rostral migratory stream (RMS) neurons in Fmr1-null mice, we observed that the absence of FMRP leads to delayed neuronal migration and altered trajectory, associated with defects of centrosomal movement. RNA-interference-induced knockdown of Fmr1 shows that these migratory defects are cell-autonomous. Notably, the primary Fmrp mRNA target implicated in these migratory defects is microtubule-associated protein 1B (MAP1B). Knocking down MAP1B expression effectively rescued most of the observed migratory defects. Finally, we elucidate the molecular mechanisms at play by demonstrating that the absence of FMRP induces defects in the cage of microtubules surrounding the nucleus of migrating neurons, which is rescued by MAP1B knockdown. Our findings reveal a novel neurodevelopmental role for FMRP in collaboration with MAP1B, jointly orchestrating neuronal migration by influencing the microtubular cytoskeleton.